John C. Bolger - 01 Jun 2021 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Director
Signature
/s/ Paul Kim, as Attorney-in-fact
Issuer symbol
FLGT
Transactions as of
01 Jun 2021
Net transactions value
-$111,142
Form type
4
Filing time
03 Jun 2021, 17:41:06 UTC
Previous filing
24 May 2021
Next filing
07 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Options Exercise $1,230 +313 +15% $3.93* 2,438 01 Jun 2021 Direct
transaction FLGT Common Stock Options Exercise $1,819 +313 +13% $5.81* 2,751 01 Jun 2021 Direct
transaction FLGT Common Stock Options Exercise $19,775 +1,250 +45% $15.82 4,001 01 Jun 2021 Direct
transaction FLGT Common Stock Sale $133,966 -1,876 -47% $71.41 2,125 01 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -313 -20% $0.000000 1,250 01 Jun 2021 Common Stock 313 $3.93 Direct F2
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -313 -11% $0.000000 2,500 01 Jun 2021 Common Stock 313 $5.81 Direct F3
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -1,250 -25% $0.000000 3,750 01 Jun 2021 Common Stock 1,250 $15.82 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple transactions at prices ranging from $71.2781 to $71.4784, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.
F3 The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.
F4 The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to Mr. Bolger's continued service for the Issuer on each vesting date.